Olema Oncology to Participate in Canaccord Genuity 2024 Horizons in Oncology Virtual Conference

SAN FRANCISCO, April 08, 2024 -- Olema Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for...

Related Keywords

Cambridge ,Cambridgeshire ,United Kingdom ,Massachusetts ,United States ,San Francisco ,California ,Seanp Bohen ,Geoffrey Mogilner ,Nasdaq ,Olema Pharmaceuticals Inc ,Chief Executive Officer ,Oncology Virtual Conference ,Vice President ,Investor Relations ,Markets ,